Why Tilray Brands may finally enter the US cannabis market
This is part of a regular series of MJBizDaily interviews with major THC industry players. To be considered for an interview, contact editorial@mjbizdaily.com. Irwin Simon sees the federal rescheduling of medical cannabis as an opportunity to redefine the entire $30...
Second state-level effort to recriminalize adult-use marijuana sales fails
An Arizona political consultant has ditched a Republican Party-backed effort to end adult-use cannabis sales in the state. And one reason why is the Trump administration’s order reclassifying medical cannabis as medicine under federal law, consultant Sean Noble told...
Cannabis MSOs sued in federal court over ‘deceptive’ medical marketing claims
Key points: Several dozen plaintiffs from 12 states filed a class-action lawsuit against three major cannabis companies. The lawsuit alleges the cannabis firms marketed adult-use cannabis products using deceptive claims of medical benefits. The plaintiffs are...
Feds hand loss to Missouri cannabis operator in labor fight
Federal labor regulators have dismissed a Missouri cannabis operator’s claim that manufacturing employees can’t unionize because they should be classified as agricultural workers. In a decision that could have wide-ranging implications for cannabis labor...
Marijuana rescheduling: How far back will 280E cannabis tax relief go?
Key points: The U.S. Treasury Department is supposed to tell cannabis operators how they can seek relief from Internal Revenue Code 280E. Cannabis operators with medical and adult-use licenses will learn more about the Internal Revenue Service policy on claiming...
Judge: Texas THCA flower sales can resume – but there’s a catch
Sales of so-called THCA flower are back on in Texas for the near future after a state judge extended a temporary pause on a statewide ban that had taken effect March 31. Ruling Friday in a lawsuit brought by companies in the state’s $5.5 billion hemp sector, Travis...
Should medical cannabis be smoked? Israel debates removing smokeable flower.
Israel’s Health Ministry is testing a question with broad implications for the global cannabis trade: Should a medical cannabis market rely on smokable flower? A ministry committee on Sunday recommended ending the use and marketing of smoked medical cannabis within...
Fuel costs and canceled orders: How the US-led war on Iran is hurting cannabis
Along with price compression and tax woes, geopolitics continues to trouble the legal cannabis industry. A sharp increase in fuel costs attributed to the U.S.-led war against Iran is rattling the cannabis industry supply chain, forcing retailers to reevaluated their...
Push to allow more hemp THC drinks in Colorado fails as federal ban looms
A push to allow hemp THC beverages to be sold in bars and restaurants in Colorado failed in the state Legislature this week. Senate Bill 164 would have created a legal pathway for sales of hemp-derived THC drinks outside of licensed cannabis retailers. But due to a...
Federal healthcare coverage for CBD is here. Hemp product standards are still needed.
(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.) The Centers for Medicare & Medicaid Services’ (CMMS) offer of limited coverage for certain hemp-derived CBD products represents a significant...
Is federal marijuana rescheduling good for Big Pharma?
Even pharmaceutical companies are celebrating marijuana rescheduling. Firms making cannabis-based drugs say the U.S. Justice Department’s reclassification of medical marijuana as a Schedule 3 drug could improve their access to private funding and public markets,...Featured
1
Latest Sponsored
